Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Micromachines
|
March 28, 2026
Integrated Experimental-Computational Framework for Drug Transport Quantification in 3D <i>Microtissues</i>™
Ramisa Fariha, Jad Hamze, Oluwanifemi David Okoh, et al.
Surgery
|
April 2, 2026
The interplay of diet and disease: High-fat feeding in chronic myocardial ischemia-A translational swine proteomics study
Jad Hamze, Dwight D Harris, Kelsey Muir, et al.
Biotech (Basel (Switzerland))
|
April 14, 2025
Developments in Extracellular Matrix-Based Angiogenesis Therapy for Ischemic Heart Disease: A Review of Current Strategies, Methodologies and Future Directions
Jad Hamze, Mark Broadwin, Christopher Stone, et al.
JTCVS Open
|
December 30, 2025
DPP-4 inhibitor linagliptin modulates myocardial metabolism in a model of coronary artery disease
Kelsey C Muir, Dwight D Harris, Christopher Stone, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
May 5, 2025
Linagliptin exerts a sex-specific effect on cardiac function, collateralization, and metabolism in a swine model of cardiometabolic disease
Kelsey C Muir, Dwight D Harris, Christopher Stone, et al.
Vascular Pharmacology
|
August 23, 2025
Sodium-glucose cotransporter 2 inhibition restores testicular microvascular perfusion via endothelial signaling in a large animal model of metabolic syndrome and heart failure
Jad Hamze, Christopher Stone, Dwight Douglas Harris, et al.
Biomedicines
|
February 26, 2025
Microvascular Dysfunction Following Cardioplegic Arrest and Cardiopulmonary Bypass: Impacts of Diabetes and Hypertension
Meghamsh Kanuparthy, Rishik Manthana, Himanshu Kaushik, et al.
Microvascular Research
|
April 28, 2026
Linagliptin enhances coronary microvascular function and collateralization in a large animal model of cardiometabolic syndrome
Kelsey C Muir, Dwight D Harris, Christopher Stone, et al.
Asian Cardiovascular & Thoracic Annals
|
July 3, 2025
Canagliflozin, a sodium-glucose cotransporter-2 inhibitor, reduces lung fibrosis in left heart dysfunction
Meghamsh Kanuparthy, Dwight D Harris, Mark Broadwin, et al.
Bioengineering (Basel, Switzerland)
|
January 28, 2026
Bioengineered Cellular and Acellular Therapies for Ischemic Heart Disease in Clinically Relevant Models
Kelsey C Muir, Clark Zheng, Keertana Yalamanchili, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Micromachines
|
March 28, 2026
Integrated Experimental-Computational Framework for Drug Transport Quantification in 3D <i>Microtissues</i>™
Ramisa Fariha, Jad Hamze, Oluwanifemi David Okoh, et al.
Surgery
|
April 2, 2026
The interplay of diet and disease: High-fat feeding in chronic myocardial ischemia-A translational swine proteomics study
Jad Hamze, Dwight D Harris, Kelsey Muir, et al.
Biotech (Basel (Switzerland))
|
April 14, 2025
Developments in Extracellular Matrix-Based Angiogenesis Therapy for Ischemic Heart Disease: A Review of Current Strategies, Methodologies and Future Directions
Jad Hamze, Mark Broadwin, Christopher Stone, et al.
JTCVS Open
|
December 30, 2025
DPP-4 inhibitor linagliptin modulates myocardial metabolism in a model of coronary artery disease
Kelsey C Muir, Dwight D Harris, Christopher Stone, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
May 5, 2025
Linagliptin exerts a sex-specific effect on cardiac function, collateralization, and metabolism in a swine model of cardiometabolic disease
Kelsey C Muir, Dwight D Harris, Christopher Stone, et al.
Vascular Pharmacology
|
August 23, 2025
Sodium-glucose cotransporter 2 inhibition restores testicular microvascular perfusion via endothelial signaling in a large animal model of metabolic syndrome and heart failure
Jad Hamze, Christopher Stone, Dwight Douglas Harris, et al.
Biomedicines
|
February 26, 2025
Microvascular Dysfunction Following Cardioplegic Arrest and Cardiopulmonary Bypass: Impacts of Diabetes and Hypertension
Meghamsh Kanuparthy, Rishik Manthana, Himanshu Kaushik, et al.
Microvascular Research
|
April 28, 2026
Linagliptin enhances coronary microvascular function and collateralization in a large animal model of cardiometabolic syndrome
Kelsey C Muir, Dwight D Harris, Christopher Stone, et al.
Asian Cardiovascular & Thoracic Annals
|
July 3, 2025
Canagliflozin, a sodium-glucose cotransporter-2 inhibitor, reduces lung fibrosis in left heart dysfunction
Meghamsh Kanuparthy, Dwight D Harris, Mark Broadwin, et al.
Bioengineering (Basel, Switzerland)
|
January 28, 2026
Bioengineered Cellular and Acellular Therapies for Ischemic Heart Disease in Clinically Relevant Models
Kelsey C Muir, Clark Zheng, Keertana Yalamanchili, et al.
Page
of 2